Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/01/2026 ,inter alia, to consider and approve availing the car loan ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals has informed BSE that its Board of Directors will meet on Monday, 5 January 2026 at 3:00 PM. The key item on the agenda is to consider and approve availing a car loan facility from HDFC Bank Ltd. The filing is made under SEBI Listing Regulations and was signed by Company Secretary Rishi Upadhaya on 2 January 2026. No financial figures or loan amount were disclosed in the intimation. The company is a small pharma entity listed on BSE (code: 544445).
Minor and routine — only a vehicle loan is being considered, so this is unlikely to materially move the stock. Investors should wait for the post-meeting outcome for the actual loan terms and amount.